Omnicell, Inc. (OMCL)
NASDAQ
Closed
Oct 23, 2026
Day's Range
36.6052 wk Range
29.09Overview - OMCL - Omnicell, Inc.
Key Statistics
Valuation
Enterprise Value
1.58B
P/E (Trailing)
43.39
P/E (Forward)
17.44
PEG Ratio
0.12
Price / Sales (TTM)
1.33
Price / Book
1.28
EV / EBITDA
19.34
Profitability
Gross Margin
48.98%
Profit Margin
3.13%
Operating Margin
5.90%
Return on Assets
1.52%
Return on Equity
3.05%
Ownership
Shares Outstanding
45.61M
Float
44.37M
Short % of Shares Outstanding
9.68%
Held by Insiders
2.14%
Held by Institutions
108.39%
Price stats
Beta
0.98
50-Day Avg
34.71
200-Day Avg
39.84
Dividends
Payout Ratio
0.00%
Analyst Consensus
8 analysts
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - OMCL - Omnicell, Inc.
Peers - OMCL - Omnicell, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - OMCL - Omnicell, Inc.
About
Omnicell, Inc. is a healthcare technology company that provides medication management solutions and adherence tools for hospitals, health systems, retail pharmacies, and other care settings. Omnicell’s portfolio includes automated dispensing systems, central pharmacy automation, robotic dispensing, IV compounding,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
